基本信息
浏览量:18
职业迁徙
个人简介
Miguel Santos holds a BSc and a MSc degree in Biochemistry, Old Dominion University, VA, USA; a PhD in Molecular Biology, ITQB/UNL, PT; a Post-Doctorate in Genomics, UA, PT; and Post Grad degrees in Project Management Proficiency (PMP Intl.), UAL, PT; Mini-MBA in Global Biopharma Entrepreneurship, Rutgers University, NJ, USA; and a MBA from the Institute of Business Management (IBM). During Miguel’s career he has managed and led several scientific projects both in academic and industry settings (ODU-USA; ITQB/UNL-Portugal; UA-Portugal; STAB VIDA, Ltd-Portugal; MWG, Gmb-Germany) and coordinated the settlement of several services and brands in the Biotechnology market. Miguel’s latest permanent position was as COO at ECBio S.A., where he worked for 11 years in the development of Advanced Therapy Medicinal Products (ATMP) based on mesenchymal stem cells (MSC). As COO at ECBio, Miguel was responsible for the company’s operations, namely those necessary to comply with both the European Medicines Agency (EMA) and national authorities’ regulations related to a) unravel MSC therapeutic mechanisms of action, and b) demonstrate safety and potency of neonatal MSC to be applied as ATMPs in the areas of osteoarthritis (OA), perypheral artery disease (PAD), myocardial infarction (MI) and auto-immune conditions undermining rare diseases. Miguel’s main activities as COO involved coordination of research projects and pre-clinical research programs in compliance with EMA/FDA regulations; project management in the scope of both national and international R&D consortia; intellectual property (IP) management; technology transfer mediation and supporting higher management in designing new-business development strategies. Miguel was also responsible for the implementation and maintenance of the Research, Development and Innovation Management System according to the NP 4457:2007 (Intl. standard based on the Oslo Manual, Eurostat/OCDE, 2005). In terms of research, Miguel continues developing projects as a Collaborating Researcher, Affiliated to the Animal Science Study Cebtre/Institute of Agricultural and Environmental Sciences and Technologies, University of Oporto (CECA/ICETA, UPorto), and to the Research Institute for Medicines, University of Lisbon (iMed/ULisboa). Miguel’s present research interests are to continue developing MSC-based AMTPs, focused on musculoskeletal conditions related to veterinary practice, but always with a One-Health perspective. Other activities involve A. Invited Principal Investigator at ITQB Nova - Coordination of the development and implementation of a Post-Graduation course in Bio-Entrepreneurship (StartUp Research Program), in collaboration with NOVA SBE, Oeiras; B. Expert, Vice-Chair and Chair for SME and Academic-driven R&D project evaluation sessions, in the scope of Horizon2020, REA/EC, Brussels; C. Member of the Executive Board of the Portuguese Society for Stem cells and Cell Therapies (SPCE-TC); D. Member of the Advanced Medicines (biologics) Evaluation Committee for the Portuguese drug approval authority, INFARMED, Lisbon.
研究兴趣
论文共 5 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Tiago L. Laundos,Francisco Vasques-Novoa, Rita N. Gomes,Vasco Sampaio-Pinto, Pedro Cruz,Helder Cruz,Jorge M. Santos,Rita N. Barcia,Perpetua Pinto-do-O,Diana S. Nascimento
Frontiers in Cell and Developmental Biology (2021)
Molecular microbiologyno. 6 (2002): 1729-1740
作者统计
#Papers: 5
#Citation: 129
H-Index: 2
G-Index: 3
Sociability: 3
Diversity: 1
Activity: 0
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn